About: Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 1974

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 1974 (uk) im April 1974 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 1974 (ast) scientific article published on 01 April 1974 (en)
publication date	wds:Q69370882-E0EFE0C3-D9F1-4A81-9617-B168A42056B1
publication date	1974-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q69370882-3205C351-0172-485D-98E4-C7F5A1C320E2
language of work or name	English
author name string	wds:Q69370882-55F1267F-E5D2-4259-865D-212CC3DBAC66 wds:Q69370882-B64BAA39-0E37-47E6-8AB6-1952A3FC9366
author name string	J Koch-Weser D W Duhme
rdfs:label	Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program (en) Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program (nl)
skos:prefLabel	Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program (en) Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program (nl)
name	Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program (en) Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program (nl)
author	wds:Q69370882-238C7A79-1DC5-47FC-BD96-A0335E99D897
author	David J. Greenblatt
title	wds:Q69370882-E844C876-4DAC-4920-B45E-A5CD096D88B4
title	Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program (en)
page(s)	wds:Q69370882-400A40EC-18A0-48DE-8045-AF6E810AFFAC
page(s)	516-519
instance of	wds:Q69370882-52A5D4F4-1EE1-4D13-ADD1-A5881A0DDCB7
instance of	scholarly article
main subject	wds:Q69370882-7268C00F-6ABF-4385-9BCA-847735030B32
main subject	toxicity
PubMed ID	wds:Q69370882-410DAFA1-5C7F-424D-A53A-E7A3D7F52C62
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4621081
PubMed ID	4621081
published in	wds:Q69370882-8EA87ACD-703C-4810-A487-2F7BC9EE7C7F
published in	Annals of Internal Medicine
issue	wds:Q69370882-35CBF762-4876-4F9B-B9E4-2E7F82857084
volume	wds:Q69370882-611AD5A8-7BAA-46B1-9C34-CF59EBBCF053
issue	4
volume	80
DOI	wds:Q69370882-8C810259-B407-43A6-845E-53C2E7A90B74
DOI	http://dx.doi.org/10.7326/0003-4819-80-4-516
DOI	10.7326/0003-4819-80-4-516
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69370882
is cites work of	Clinical use of serum digoxin concentrations Digitalis Assay and Its Clinical Application The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing The serum level approach to individualization of drug dosage Digoxin therapy: textbooks, theory and practice Digoxin dosage in renal insufficiency: impracticality of basing it on the creatinine clearance, body weight and volume of distribution. Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes? Serum digoxin concentration and diagnosis of digitalis toxicity. Current concepts Pharmacologic treatment of cardiac arrhythmias: 25 years of progress Overview of therapeutic drug monitoring The challenge of in-hospital medication use: an opportunity for clinical pharmacology Therapeutic drug monitoring for tomorrow. Association between clinical cardiac status, laboratory parameters, and digoxin usage Recognition and management of digitalis toxicity Studies on digitalis. XIII. A prospective study of 649 patients on maintenance treatment with digitoxin The changing pattern of toxicity of digoxin Role of serum digoxin assay in patient management Evaluation of Therapeutic Drug Monitoring in a Long-Term Care Facility: A Pilot Project Part I Digitalis glycosides: Mechanisms and manifestations of toxicity Comparison of drug dosing methods Part II Digitalis glycosides: Mechanisms and manifestations of toxicity Plasma concentrations of digoxin in patients under intensive care conditions and in patients undergoing anesthesia and operation (author' transl) One hundred digitalis blood levels. A utilization review Therapeutic drug monitoring and patient outcome. A review of the issues Current Considerations in Digoxin Usage Pitfalls in the application of digoxin determinations Clinical Pharmacokinetics of Digoxin in Infants Digitalis Therapy in Heart Failure: A Rational Approach Pharmacogenetics: the therapeutic drug monitoring of the future? Drug monitoring in the elderly A standard approach to compiling clinical pharmacokinetic data Treatment of congestive cardiomyopathy Quality of requests for serum digoxin concentrations: experience from an Australian regional health service. Serum digoxin levels and mortality in 5,100 patients Monitoring digoxin therapy: III. How useful are the nomograms? Increasing therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology Therapeutic drug monitoring beyond 2000 The Treatment of Common Cardiac Arrhythmias Digoxin toxicity in the aged. Characterising and avoiding the problem Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied. Digitalis toxicity in infants and children Magnesium therapy in massive digoxin intoxication Digitalis poisoning: Historical and forensic aspects Digoxin Toxicity : Evaluation in Clinical Practice with Pharmacokinetic Correlations A column radioimmunoassay method for the determination of digoxin Development of a computerised decisions support system for renal risk drugs targeting primary healthcare Surveillance of test use. The contribution of laboratory medicine to clinical pharmacology Monitoring of Antiarrhythmic Drug Levels: Values and Pitfalls Etiology of intoxication: a study of 557 cases A DNA-Based Assay for Digoxin Detection. Efficiency of individual dosage of digoxin with calculated concentration Use of serum drug concentrations in surgical patients
is cites work of	wds:Q36303992-89D8476F-7371-4218-A6AC-1D40FC10B399 wds:Q34515259-52F2DD49-3E68-475E-B15A-05FB88C18DB2 wds:Q40268837-9A0222D1-0F3C-4481-9601-4C0B1C720499 wds:Q37409151-34B5E9DF-F7A0-4268-8E40-7E56B2F288AE

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software